Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).

被引：0
|
作者：
Puerto, VL
Cardenas, J
Lara, F
Goana, R
Silva, A
Barroso, N
机构：
[1] IMSS CMN Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Estatal Cancerol, Colima, Mexico
[3] INCAN, Tlalpan, Mexico
[4] Hosp Gen Dr M Silva, Morelia, Michoacan, Mexico
[5] Hosp Dr A Leano, Zapopan, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
512
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [1] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [2] Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Nisticò, C
    De Matteis, A
    Ross, E
    Carnino, F
    Valenza, R
    Agostara, B
    Bria, E
    Farris, A
    Cremonesi, M
    D'Ottavio, AM
    Vaccaro, A
    Garufi, C
    Giunta, S
    Botti, C
    Perrone, F
    Terzoli, E
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1343 - 1348
  • [3] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [4] Vinorelbine and farmorubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Gaafar, RM
    Hamza, MR
    ElZawahry, H
    Khaled, H
    Helal, A
    Eissa, S
    AbdelBaki, H
    ElKalaawy, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S329 - S329
  • [5] Phase II study of neaodajuvant chemotherapy combining epirubicin cyclophosphamide and vinorelbine (NEC) in locally advanced breast cancer (LABC): Preliminary results
    Braud, AC
    Jauffret, E
    Kirova, YM
    Piedbois, P
    Levy, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S206 - S206
  • [6] Induction preoperative chemotherapy with high-dose epirubicin in locally advanced breast cancer (LABC)
    Silvestro, P
    DAiuto, G
    Caparrotti, G
    Menditto, C
    Tambaro, R
    Rinaldi, L
    Pergola, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 713 - 713
  • [7] Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
    Abramova, Natalya A.
    Vladimirova, Liubov Yu
    Shikhliarova, Alla I.
    Storozhakova, Anna E.
    Kova, Valeriya S. Myag
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST-CANCER (LABC)
    SWAIN, S
    LIPPMAN, M
    BAGLEY, C
    SORACE, R
    WESLEY, M
    CANCER DRUG DELIVERY, 1986, 3 (01): : 55 - 55
  • [9] Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer
    Han, S.
    Kwak, K.
    Kim, J.
    Kim, J.
    Park, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
  • [10] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
12345